» Articles » PMID: 38406640

Adenine's Impact on Mice's Gut and Kidney Varies with the Dosage Administered and Relates to Intestinal Microorganisms and Enzyme Activities

Overview
Journal 3 Biotech
Publisher Springer
Specialty Biotechnology
Date 2024 Feb 26
PMID 38406640
Authors
Affiliations
Soon will be listed here.
Abstract

This study aimed to investigate the effects of different dosages of adenine on intestinal microorganisms and enzyme activities, laying the experimental groundwork for subsequent exploration of the microbial mechanisms underlying diarrhea with kidney yang deficiency syndrome. Twenty-four mice were assigned to the following four groups: the control (NC) group, low-dosage adenine (NML) group, middle-dosage adenine (NMM) group, and high-dosage adenine (NMH) group. Mice in the NML, NMM, and NMH groups received 25 mg/(kg·d), 50 mg/(kg·d), and 100 mg/(kg·d) of adenine, respectively, 0.4 mL/each, once a day for 14 days. The NC group received 0.4 mL sterile water. Parameters including body weight, rectal temperature, intestinal microorganisms, enzyme activities, and microbial activity were measured. Results indicated that mice in the experimental group displayed signs of a poor mental state, curled up with their backs arched, and felt sleepy and lazy, with sparse fur that was easily shed, and damp bedding. Some mice showed fecal adhesion contamination in the perianal and tail areas. Dosage-dependent effects were observed, with decreased food intake, body weight, rectal temperature, and microbial activity and increased water intake and fecal water content. Enzyme activity analyses revealed significantly higher activities of protease, sucrase, amylase, and cellulase in intestinal contents and lactase, sucrase, amylase, and cellulase in the mucosa of the NMM group compared to those of other groups. Ultimately, the higher adenine dosage was associated with more pronounced symptoms of kidney yang deficiency syndrome, with 50 mg/kg adenine exhibiting the most substantial impact on the number of intestinal microbial colonies and enzyme activities.

Citing Articles

The intestinal microbiota modulates the visceral sensitivity involved in IBS induced by restraint combined with tail clustering.

Deng N, Xie S, Liu Q, Peng H, Fang L, Shen J Front Cell Infect Microbiol. 2025; 15:1549617.

PMID: 40051709 PMC: 11882872. DOI: 10.3389/fcimb.2025.1549617.


Investigating the biological significance of the TCM principle "promoting urination to regulate bowel movements" through the influence of the intestinal microbiota and their metabolites on the renal-intestinal axis.

Yu D, Shen J, Li L, Long Q, Xie S, Zhou M Front Cell Infect Microbiol. 2025; 14:1523708.

PMID: 39867340 PMC: 11757259. DOI: 10.3389/fcimb.2024.1523708.


Study on the effects of Massa Medicata Fermentata with different formulations on the intestinal microbiota and enzyme activities in mice with spleen deficiency constipation.

Liang X, Wan D, Li X, Peng Y, Chen L Front Cell Infect Microbiol. 2025; 14():1524327.

PMID: 39844840 PMC: 11753248. DOI: 10.3389/fcimb.2024.1524327.


Zhuanggu Shubi ointment mediated the characteristic bacteria-intestinal mucosal barrier-bone metabolism axis to intervene in postmenopausal osteoporosis.

Li X, Li N, Pei H, Ren Y, Li L, Sun L Front Cell Infect Microbiol. 2024; 14:1500111.

PMID: 39698319 PMC: 11652507. DOI: 10.3389/fcimb.2024.1500111.


Involvement of intestinal mucosal microbiota in adenine-induced liver function injury.

Fang L, Shen J, Wu Y, Tan Z 3 Biotech. 2024; 15(1):6.

PMID: 39676888 PMC: 11638458. DOI: 10.1007/s13205-024-04180-7.


References
1.
Li X, Deng N, Zheng T, Qiao B, Peng M, Xiao N . Importance of in improving the adverse effects of high-fat diet on mice associated with intestinal contents microbiota. Front Nutr. 2022; 9:957334. PMC: 9365999. DOI: 10.3389/fnut.2022.957334. View

2.
Schulster M, Bernie A, Ramasamy R . The role of estradiol in male reproductive function. Asian J Androl. 2016; 18(3):435-40. PMC: 4854098. DOI: 10.4103/1008-682X.173932. View

3.
Jaworska K, Hering D, Mosieniak G, Bielak-Zmijewska A, Pilz M, Konwerski M . TMA, A Forgotten Uremic Toxin, but Not TMAO, Is Involved in Cardiovascular Pathology. Toxins (Basel). 2019; 11(9). PMC: 6784008. DOI: 10.3390/toxins11090490. View

4.
Ai S, Li Y, Tao J, Zheng H, Tian L, Wang Y . Bibliometric visualization analysis of gut-kidney axis from 2003 to 2022. Front Physiol. 2023; 14:1176894. PMC: 10287975. DOI: 10.3389/fphys.2023.1176894. View

5.
Ramezani A, Raj D . The gut microbiome, kidney disease, and targeted interventions. J Am Soc Nephrol. 2013; 25(4):657-70. PMC: 3968507. DOI: 10.1681/ASN.2013080905. View